Immunis Inc. Featured by DelveInsight for Recent Developments in Knee Osteoarthritis Research>
IRVINE, Calif.—January 16, 2023—Immunis Inc. was featured by DelveInsight Business Research LLP as one of six companies with recent developments in researching a treatment for knee osteoarthritis. DelveInsight is a leading Business Consultant and Market Research Firm that examines the innovative landscape of the healthcare industry to inform decision-makers on critical issues and opportunities. For more information about the article, read here.